{"transactions":[{"id":981661,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T16:30:19.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":191854,"price":5.9826,"value":1147785.7404,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.2794 to $5.855. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":13728924,"source":{"system":"sec-edgar","filing":"0001493152-25-025970","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225025970/ownership.xml","form_type":"4"}},{"id":985148,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T16:30:07.000Z","date":"2025-11-28","kind":"sale","planned":true,"acquired":false,"shares":61493,"price":6.44,"value":396014.92,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.3396 to $6.5398. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":13920778,"source":{"system":"sec-edgar","filing":"0001493152-25-025571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225025571/ownership.xml","form_type":"4"}},{"id":985147,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T16:30:07.000Z","date":"2025-11-26","kind":"sale","planned":true,"acquired":false,"shares":127938,"price":6.391,"value":817651.758,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.2498 to $6.50. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":13982271,"source":{"system":"sec-edgar","filing":"0001493152-25-025571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225025571/ownership.xml","form_type":"4"}},{"id":987201,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-26T16:30:21.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":235971,"price":6.38,"value":1505494.98,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.12 to $6.6094. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14110209,"source":{"system":"sec-edgar","filing":"0001493152-25-025161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225025161/ownership.xml","form_type":"4"}},{"id":987200,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-26T16:30:21.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":227803,"price":6.1491,"value":1400783.4273,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.93 to $6.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14346180,"source":{"system":"sec-edgar","filing":"0001493152-25-025161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225025161/ownership.xml","form_type":"4"}},{"id":1011373,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-30T16:30:13.000Z","date":"2025-10-29","kind":"sale","planned":true,"acquired":false,"shares":100,"price":6.49,"value":649.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14573983,"source":{"system":"sec-edgar","filing":"0001493152-25-020240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225020240/ownership.xml","form_type":"4"}},{"id":1011372,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-30T16:30:13.000Z","date":"2025-10-28","kind":"sale","planned":true,"acquired":false,"shares":24453,"price":6.5025,"value":159005.6325,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.49 to $6.55. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14574083,"source":{"system":"sec-edgar","filing":"0001493152-25-020240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225020240/ownership.xml","form_type":"4"}},{"id":1012598,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-28T16:30:11.000Z","date":"2025-10-27","kind":"sale","planned":true,"acquired":false,"shares":66403,"price":6.0477,"value":401585.4231,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.93 to $6.18. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14598536,"source":{"system":"sec-edgar","filing":"0001493152-25-019892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225019892/ownership.xml","form_type":"4"}},{"id":1012597,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-28T16:30:11.000Z","date":"2025-10-24","kind":"sale","planned":true,"acquired":false,"shares":46696,"price":5.9595,"value":278284.812,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.92 to $6.0212. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14664939,"source":{"system":"sec-edgar","filing":"0001493152-25-019892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225019892/ownership.xml","form_type":"4"}},{"id":1013840,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-24T16:30:12.000Z","date":"2025-10-23","kind":"sale","planned":true,"acquired":false,"shares":154383,"price":5.9898,"value":924723.2934,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.92 to $6.177. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14711635,"source":{"system":"sec-edgar","filing":"0001493152-25-019309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225019309/ownership.xml","form_type":"4"}},{"id":1013839,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-24T16:30:12.000Z","date":"2025-10-22","kind":"sale","planned":true,"acquired":false,"shares":144266,"price":6.1529,"value":887654.2714,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.08 to $6.2552. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14866018,"source":{"system":"sec-edgar","filing":"0001493152-25-019309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225019309/ownership.xml","form_type":"4"}},{"id":1014749,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-22T16:30:08.000Z","date":"2025-10-21","kind":"sale","planned":true,"acquired":false,"shares":109675,"price":6.3002,"value":690974.435,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.12 to $6.4406. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15010284,"source":{"system":"sec-edgar","filing":"0001493152-25-018917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018917/ownership.xml","form_type":"4"}},{"id":1014748,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-22T16:30:08.000Z","date":"2025-10-20","kind":"sale","planned":true,"acquired":false,"shares":220535,"price":6.1998,"value":1367272.893,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.07 to $6.2961. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15119959,"source":{"system":"sec-edgar","filing":"0001493152-25-018917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018917/ownership.xml","form_type":"4"}},{"id":1016827,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-17T16:15:23.000Z","date":"2025-10-16","kind":"sale","planned":true,"acquired":false,"shares":12844,"price":6.1014,"value":78366.3816,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.07 to $6.1451. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15340494,"source":{"system":"sec-edgar","filing":"0001493152-25-018462","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018462/ownership.xml","form_type":"4"}},{"id":1016826,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-17T16:15:23.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":16671,"price":6.0702,"value":101196.3042,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.07 to $6.0765. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15353338,"source":{"system":"sec-edgar","filing":"0001493152-25-018462","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018462/ownership.xml","form_type":"4"}},{"id":1019311,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-14T16:30:16.000Z","date":"2025-10-10","kind":"sale","planned":true,"acquired":false,"shares":2300,"price":6.0752,"value":13972.96,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.07 to $6.09. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15370009,"source":{"system":"sec-edgar","filing":"0001493152-25-018021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018021/ownership.xml","form_type":"4"}},{"id":1019310,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-14T16:30:16.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":249060,"price":6.1428,"value":1529925.768,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.9625 to $6.35. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15372309,"source":{"system":"sec-edgar","filing":"0001493152-25-018021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018021/ownership.xml","form_type":"4"}},{"id":1020845,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-09T16:30:20.000Z","date":"2025-10-08","kind":"sale","planned":true,"acquired":false,"shares":466242,"price":6.0479,"value":2819784.9918,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.6101 to $6.325. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15621369,"source":{"system":"sec-edgar","filing":"0001493152-25-017612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225017612/ownership.xml","form_type":"4"}},{"id":1020844,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-09T16:30:20.000Z","date":"2025-10-07","kind":"sale","planned":true,"acquired":false,"shares":72133,"price":5.6029,"value":404153.9857,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.52 to $5.675. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16087611,"source":{"system":"sec-edgar","filing":"0001493152-25-017612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225017612/ownership.xml","form_type":"4"}},{"id":1022253,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-07T16:30:30.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":73955,"price":5.6878,"value":420641.249,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.58 to $5.82. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments"}],"balance_after":16159744,"source":{"system":"sec-edgar","filing":"0001493152-25-017300","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225017300/ownership.xml","form_type":"4"}},{"id":1022252,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-07T16:30:30.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":450342,"price":5.5553,"value":2501784.9126,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.355 to $5.823. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments"}],"balance_after":16233699,"source":{"system":"sec-edgar","filing":"0001493152-25-017300","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225017300/ownership.xml","form_type":"4"}},{"id":1190986,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-26T21:00:04.000Z","date":"2025-03-24","kind":"sale","planned":false,"acquired":false,"shares":10000000,"price":9.15,"value":91500000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":48070273,"source":{"system":"sec-edgar","filing":"0001641172-25-000811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000164117225000811/ownership.xml","form_type":"4"}},{"id":1325469,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-12-19T21:00:04.000Z","date":"2024-12-17","kind":"sale","planned":false,"acquired":false,"shares":10000000,"price":6.33,"value":63300000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":58070273,"source":{"system":"sec-edgar","filing":"0001493152-24-050856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315224050856/ownership.xml","form_type":"4"}},{"id":1405237,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-17T21:00:05.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":7500000,"price":6.24,"value":46800000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":68070273,"source":{"system":"sec-edgar","filing":"0001493152-24-036915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315224036915/ownership.xml","form_type":"4"}},{"id":1509058,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-20T21:00:14.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":16900000,"price":4.3,"value":72670000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":75570273,"source":{"system":"sec-edgar","filing":"0001493152-24-020806","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315224020806/ownership.xml","form_type":"4"}},{"id":1680808,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-01-11T21:00:11.000Z","date":"2024-01-09","kind":"sale","planned":false,"acquired":false,"shares":10000000,"price":3.66,"value":36600000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":92470273,"source":{"system":"sec-edgar","filing":"0001493152-24-002111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315224002111/ownership.xml","form_type":"4"}},{"id":1707381,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-12-18T21:00:34.000Z","date":"2023-12-14","kind":"sale","planned":false,"acquired":false,"shares":14895000,"price":2.66,"value":39620700.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":102470273,"source":{"system":"sec-edgar","filing":"0001493152-23-045325","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315223045325/ownership.xml","form_type":"4"}},{"id":1836504,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T21:00:10.000Z","date":"2023-06-30","kind":"sale","planned":false,"acquired":false,"shares":700,"price":25.11,"value":17577.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16684041,"source":{"system":"sec-edgar","filing":"0000899243-23-017010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323017010/doc4.xml","form_type":"4"}},{"id":1841152,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-30T21:00:09.000Z","date":"2023-06-29","kind":"sale","planned":false,"acquired":false,"shares":89942,"price":25.1799,"value":2264730.5658,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.37. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16684741,"source":{"system":"sec-edgar","filing":"0000899243-23-016775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016775/doc4.xml","form_type":"4"}},{"id":1841151,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-30T21:00:09.000Z","date":"2023-06-28","kind":"sale","planned":false,"acquired":false,"shares":7010,"price":25.0958,"value":175921.558,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.15. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16774683,"source":{"system":"sec-edgar","filing":"0000899243-23-016775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016775/doc4.xml","form_type":"4"}},{"id":1846600,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-22T21:00:13.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":9902,"price":25.1769,"value":249301.6638,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.16 to $25.2603. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16781693,"source":{"system":"sec-edgar","filing":"0000899243-23-016308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016308/doc4.xml","form_type":"4"}},{"id":1849670,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T21:00:11.000Z","date":"2023-06-16","kind":"sale","planned":false,"acquired":false,"shares":17037,"price":26.1304,"value":445183.6248,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.13 to $26.16. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16791595,"source":{"system":"sec-edgar","filing":"0000899243-23-016075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016075/doc4.xml","form_type":"4"}},{"id":1849669,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T21:00:11.000Z","date":"2023-06-16","kind":"sale","planned":false,"acquired":false,"shares":111107,"price":25.3251,"value":2813795.8857,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.16 to $25.9131. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16808632,"source":{"system":"sec-edgar","filing":"0000899243-23-016075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016075/doc4.xml","form_type":"4"}},{"id":1849668,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T21:00:11.000Z","date":"2023-06-15","kind":"sale","planned":false,"acquired":false,"shares":2417,"price":26.0195,"value":62889.1315,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.04. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16919739,"source":{"system":"sec-edgar","filing":"0000899243-23-016075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016075/doc4.xml","form_type":"4"}},{"id":1849667,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T21:00:11.000Z","date":"2023-06-15","kind":"sale","planned":false,"acquired":false,"shares":52765,"price":25.8465,"value":1363790.5725,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.585 to $25.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16922156,"source":{"system":"sec-edgar","filing":"0000899243-23-016075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016075/doc4.xml","form_type":"4"}},{"id":1854486,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:00:11.000Z","date":"2023-06-14","kind":"sale","planned":false,"acquired":false,"shares":36281,"price":26.2431,"value":952125.9111,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.6587. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16974921,"source":{"system":"sec-edgar","filing":"0000899243-23-015663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323015663/doc4.xml","form_type":"4"}},{"id":1854485,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:00:11.000Z","date":"2023-06-14","kind":"sale","planned":false,"acquired":false,"shares":20967,"price":25.9213,"value":543491.8971,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.77 to $25.9999. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17011202,"source":{"system":"sec-edgar","filing":"0000899243-23-015663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323015663/doc4.xml","form_type":"4"}},{"id":1854484,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:00:11.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":70307,"price":27.2307,"value":1914508.8249,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.49. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17032169,"source":{"system":"sec-edgar","filing":"0000899243-23-015663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323015663/doc4.xml","form_type":"4"}},{"id":1854483,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:00:11.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":36547,"price":26.8058,"value":979671.5726,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.6169 to $26.9997. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17102476,"source":{"system":"sec-edgar","filing":"0000899243-23-015663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323015663/doc4.xml","form_type":"4"}},{"id":1860728,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":4,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-09T21:00:08.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":15000000,"price":3.69,"value":55350000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":117365273,"source":{"system":"sec-edgar","filing":"0000899243-23-015323","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323015323/doc4.xml","form_type":"4"}},{"id":1865258,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T21:00:10.000Z","date":"2023-06-05","kind":"sale","planned":false,"acquired":false,"shares":5197,"price":27.3231,"value":141998.1507,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.29 to $27.37. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17139023,"source":{"system":"sec-edgar","filing":"0000899243-23-014628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323014628/doc4.xml","form_type":"4"}},{"id":1865257,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T21:00:10.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":34365,"price":27.3165,"value":938731.5225,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.29 to $27.36. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17144220,"source":{"system":"sec-edgar","filing":"0000899243-23-014628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323014628/doc4.xml","form_type":"4"}},{"id":1878228,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-24","kind":"sale","planned":false,"acquired":false,"shares":2323,"price":27.1155,"value":62989.3065,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.24. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17178585,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1878227,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-24","kind":"sale","planned":false,"acquired":false,"shares":66754,"price":26.2527,"value":1752472.7358,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17180908,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1878226,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-24","kind":"sale","planned":false,"acquired":false,"shares":35307,"price":25.8911,"value":914137.0677,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.77 to $25.9988. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17247662,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1878225,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":23348,"price":27.0159,"value":630767.2332,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.045. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17282969,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1878224,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":144402,"price":26.6104,"value":3842594.9808,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.9999. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17306317,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1878223,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":2317,"price":25.8385,"value":59867.8045,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.73 to $25.9992. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17450719,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1881190,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:00:09.000Z","date":"2023-05-22","kind":"sale","planned":false,"acquired":false,"shares":91896,"price":25.7237,"value":2363905.1352,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.37 to $25.91. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17453036,"source":{"system":"sec-edgar","filing":"0000899243-23-013759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013759/doc4.xml","form_type":"4"}},{"id":1881189,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:00:09.000Z","date":"2023-05-19","kind":"sale","planned":false,"acquired":false,"shares":91651,"price":25.3814,"value":2326230.6914,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.15 to $25.72. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17544932,"source":{"system":"sec-edgar","filing":"0000899243-23-013759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013759/doc4.xml","form_type":"4"}},{"id":1899629,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-09T21:00:13.000Z","date":"2023-05-05","kind":"sale","planned":false,"acquired":false,"shares":136,"price":25.1032,"value":3414.0352,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.09 to $25.14. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17636583,"source":{"system":"sec-edgar","filing":"0000899243-23-012478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323012478/doc4.xml","form_type":"4"}},{"id":1902935,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T21:00:15.000Z","date":"2023-05-04","kind":"sale","planned":false,"acquired":false,"shares":114332,"price":25.5498,"value":2921159.7336,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.76. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17636719,"source":{"system":"sec-edgar","filing":"0000899243-23-012410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323012410/doc4.xml","form_type":"4"}},{"id":1902934,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T21:00:15.000Z","date":"2023-05-03","kind":"sale","planned":false,"acquired":false,"shares":83674,"price":25.512,"value":2134691.088,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.29 to $25.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17751051,"source":{"system":"sec-edgar","filing":"0000899243-23-012410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323012410/doc4.xml","form_type":"4"}},{"id":1906241,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T21:00:07.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":3075,"price":25.3047,"value":77811.9525,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.28 to $25.35. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17834725,"source":{"system":"sec-edgar","filing":"0000899243-23-012176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323012176/doc4.xml","form_type":"4"}},{"id":1913382,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-26T21:00:12.000Z","date":"2023-04-25","kind":"sale","planned":false,"acquired":false,"shares":961,"price":25.2999,"value":24313.2039,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.28 to $25.3692. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17837800,"source":{"system":"sec-edgar","filing":"0000899243-23-011791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011791/doc4.xml","form_type":"4"}},{"id":1913381,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-26T21:00:12.000Z","date":"2023-04-24","kind":"sale","planned":false,"acquired":false,"shares":66038,"price":25.4192,"value":1678633.1296,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.28 to $25.88. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17838761,"source":{"system":"sec-edgar","filing":"0000899243-23-011791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011791/doc4.xml","form_type":"4"}},{"id":1914945,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-24T21:00:08.000Z","date":"2023-04-21","kind":"sale","planned":false,"acquired":false,"shares":15908,"price":26.0091,"value":413752.7628,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.14. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17904799,"source":{"system":"sec-edgar","filing":"0000899243-23-011617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011617/doc4.xml","form_type":"4"}},{"id":1914944,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-24T21:00:08.000Z","date":"2023-04-21","kind":"sale","planned":false,"acquired":false,"shares":289485,"price":25.7647,"value":7458494.1795,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.28 to $25.9999. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17920707,"source":{"system":"sec-edgar","filing":"0000899243-23-011617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011617/doc4.xml","form_type":"4"}},{"id":1914943,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-24T21:00:08.000Z","date":"2023-04-20","kind":"sale","planned":false,"acquired":false,"shares":6590,"price":25.0603,"value":165147.377,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.07. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18210192,"source":{"system":"sec-edgar","filing":"0000899243-23-011617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011617/doc4.xml","form_type":"4"}},{"id":1916512,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-20T21:00:09.000Z","date":"2023-04-19","kind":"sale","planned":false,"acquired":false,"shares":76114,"price":25.1198,"value":1911968.4572,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.24. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18216782,"source":{"system":"sec-edgar","filing":"0000899243-23-011512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011512/doc4.xml","form_type":"4"}},{"id":1916511,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-20T21:00:09.000Z","date":"2023-04-18","kind":"sale","planned":false,"acquired":false,"shares":6953,"price":25.1203,"value":174661.4459,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.2624. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18292896,"source":{"system":"sec-edgar","filing":"0000899243-23-011512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011512/doc4.xml","form_type":"4"}},{"id":1918186,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T21:00:06.000Z","date":"2023-04-17","kind":"sale","planned":false,"acquired":false,"shares":10524,"price":25.0609,"value":263740.9116,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.08. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18299849,"source":{"system":"sec-edgar","filing":"0000899243-23-011414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011414/doc4.xml","form_type":"4"}},{"id":1918185,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T21:00:06.000Z","date":"2023-04-14","kind":"sale","planned":false,"acquired":false,"shares":9565,"price":25.1074,"value":240152.281,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.189. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18310373,"source":{"system":"sec-edgar","filing":"0000899243-23-011414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011414/doc4.xml","form_type":"4"}},{"id":1996113,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-23T21:00:24.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":2925,"price":29.0755,"value":85045.8375,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.0067 to $29.1558. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18319938,"source":{"system":"sec-edgar","filing":"0000899243-23-006057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323006057/doc4.xml","form_type":"4"}},{"id":1996112,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-23T21:00:24.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":63946,"price":28.5137,"value":1823337.0602,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.0053 to $28.9976. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18322863,"source":{"system":"sec-edgar","filing":"0000899243-23-006057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323006057/doc4.xml","form_type":"4"}},{"id":1996111,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-23T21:00:24.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":7364,"price":27.4893,"value":202431.2052,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.02 to $27.9986. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18386809,"source":{"system":"sec-edgar","filing":"0000899243-23-006057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323006057/doc4.xml","form_type":"4"}},{"id":1996110,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-23T21:00:24.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":242,"price":26.95,"value":6521.9,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18394173,"source":{"system":"sec-edgar","filing":"0000899243-23-006057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323006057/doc4.xml","form_type":"4"}},{"id":2007855,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T21:00:19.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":38964,"price":26.7525,"value":1042384.41,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.72 to $26.86. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18394415,"source":{"system":"sec-edgar","filing":"0000899243-23-005577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323005577/doc4.xml","form_type":"4"}},{"id":2013709,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-15T21:00:22.000Z","date":"2023-02-14","kind":"sale","acquired":false,"shares":38907,"price":26.8103,"value":1043108.3421,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.72 to $26.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18433379,"source":{"system":"sec-edgar","filing":"0000899243-23-005183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323005183/doc4.xml","form_type":"4"}},{"id":2013708,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-15T21:00:22.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":52250,"price":26.1401,"value":1365820.225,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.29. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18472286,"source":{"system":"sec-edgar","filing":"0000899243-23-005183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323005183/doc4.xml","form_type":"4"}},{"id":2013707,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-15T21:00:22.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":26800,"price":25.7748,"value":690764.64,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.31 to $25.995. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18524536,"source":{"system":"sec-edgar","filing":"0000899243-23-005183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323005183/doc4.xml","form_type":"4"}},{"id":2020140,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T21:00:29.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":84408,"price":26.1586,"value":2207995.1088,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.39. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18551336,"source":{"system":"sec-edgar","filing":"0000899243-23-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004850/doc4.xml","form_type":"4"}},{"id":2020139,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T21:00:29.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":12813,"price":25.935,"value":332305.155,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.76 to $25.9985. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18635744,"source":{"system":"sec-edgar","filing":"0000899243-23-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004850/doc4.xml","form_type":"4"}},{"id":2020138,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T21:00:29.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":9490,"price":27.1713,"value":257855.637,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.31. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18648557,"source":{"system":"sec-edgar","filing":"0000899243-23-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004850/doc4.xml","form_type":"4"}},{"id":2020137,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T21:00:29.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":127016,"price":26.3253,"value":3343734.3048,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18658047,"source":{"system":"sec-edgar","filing":"0000899243-23-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004850/doc4.xml","form_type":"4"}},{"id":2020136,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T21:00:29.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":544,"price":25.9904,"value":14138.7776,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.99 to $25.9955. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18785063,"source":{"system":"sec-edgar","filing":"0000899243-23-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004850/doc4.xml","form_type":"4"}},{"id":2024872,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:00:19.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":1300,"price":29,"value":37700.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18785607,"source":{"system":"sec-edgar","filing":"0000899243-23-004510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004510/doc4.xml","form_type":"4"}},{"id":2024871,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:00:19.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":44498,"price":28.313,"value":1259871.874,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.90. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18786907,"source":{"system":"sec-edgar","filing":"0000899243-23-004510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004510/doc4.xml","form_type":"4"}},{"id":2024870,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:00:19.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":36116,"price":27.317,"value":986580.772,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.04 to $27.9951. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18831405,"source":{"system":"sec-edgar","filing":"0000899243-23-004510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004510/doc4.xml","form_type":"4"}},{"id":2024869,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:00:19.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":59066,"price":29.3559,"value":1733935.5894,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18867521,"source":{"system":"sec-edgar","filing":"0000899243-23-004510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004510/doc4.xml","form_type":"4"}},{"id":2024868,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:00:19.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":4442,"price":28.9195,"value":128460.419,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.85 to $28.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18926587,"source":{"system":"sec-edgar","filing":"0000899243-23-004510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004510/doc4.xml","form_type":"4"}},{"id":2028619,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T21:00:11.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":14752,"price":30.0942,"value":443949.6384,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.24. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18931029,"source":{"system":"sec-edgar","filing":"0000899243-23-004262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004262/doc4.xml","form_type":"4"}},{"id":2028618,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T21:00:11.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":30497,"price":29.8357,"value":909899.3429,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.51 to $29.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18945781,"source":{"system":"sec-edgar","filing":"0000899243-23-004262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004262/doc4.xml","form_type":"4"}},{"id":2028617,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T21:00:11.000Z","date":"2023-02-03","kind":"sale","acquired":false,"shares":62468,"price":30.4561,"value":1902531.6548,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.085 to $30.94. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18976278,"source":{"system":"sec-edgar","filing":"0000899243-23-004262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004262/doc4.xml","form_type":"4"}},{"id":2028616,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T21:00:11.000Z","date":"2023-02-03","kind":"sale","acquired":false,"shares":6318,"price":29.8517,"value":188603.0406,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.35 to $29.98. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19038746,"source":{"system":"sec-edgar","filing":"0000899243-23-004262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004262/doc4.xml","form_type":"4"}},{"id":2033186,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T21:00:13.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":86801,"price":29.7003,"value":2578015.7403,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.15 to $29.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19045064,"source":{"system":"sec-edgar","filing":"0000899243-23-003957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003957/doc4.xml","form_type":"4"}},{"id":2033185,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T21:00:13.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":35173,"price":29.1948,"value":1026868.7004,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.52. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19131865,"source":{"system":"sec-edgar","filing":"0000899243-23-003957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003957/doc4.xml","form_type":"4"}},{"id":2033184,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T21:00:13.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":26661,"price":28.7795,"value":767290.2495,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.5431 to $28.9958. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19167038,"source":{"system":"sec-edgar","filing":"0000899243-23-003957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003957/doc4.xml","form_type":"4"}},{"id":2038602,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T21:00:11.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":70567,"price":29.4965,"value":2081479.5155,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.77. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19193699,"source":{"system":"sec-edgar","filing":"0000899243-23-003181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003181/doc4.xml","form_type":"4"}},{"id":2038601,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T21:00:11.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":3316,"price":28.8758,"value":95752.1528,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.70 to $28.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19264266,"source":{"system":"sec-edgar","filing":"0000899243-23-003181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003181/doc4.xml","form_type":"4"}},{"id":2038600,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T21:00:11.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":11904,"price":30.2113,"value":359635.3152,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.7185. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19267582,"source":{"system":"sec-edgar","filing":"0000899243-23-003181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003181/doc4.xml","form_type":"4"}},{"id":2038599,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T21:00:11.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":67026,"price":29.324,"value":1965470.424,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.02 to $29.9999. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19279486,"source":{"system":"sec-edgar","filing":"0000899243-23-003181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003181/doc4.xml","form_type":"4"}},{"id":2046451,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:00:13.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":30112,"price":28.4531,"value":856779.7472,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.83. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19346512,"source":{"system":"sec-edgar","filing":"0000899243-23-002713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323002713/doc4.xml","form_type":"4"}},{"id":2046450,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:00:13.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":6400,"price":27.8012,"value":177927.68,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $27.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19376624,"source":{"system":"sec-edgar","filing":"0000899243-23-002713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323002713/doc4.xml","form_type":"4"}},{"id":2048756,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-23T21:00:16.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":122773,"price":27.5065,"value":3377055.5245,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.62. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19383024,"source":{"system":"sec-edgar","filing":"0000899243-23-002444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323002444/doc4.xml","form_type":"4"}},{"id":2048755,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-23T21:00:16.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":21585,"price":26.8587,"value":579745.0395,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.41 to $26.9955. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19505797,"source":{"system":"sec-edgar","filing":"0000899243-23-002444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323002444/doc4.xml","form_type":"4"}},{"id":2048754,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-23T21:00:16.000Z","date":"2023-01-19","kind":"sale","acquired":false,"shares":65802,"price":26.5929,"value":1749866.0058,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.94. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19527382,"source":{"system":"sec-edgar","filing":"0000899243-23-002444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323002444/doc4.xml","form_type":"4"}},{"id":2048753,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-23T21:00:16.000Z","date":"2023-01-19","kind":"sale","acquired":false,"shares":4037,"price":25.9461,"value":104744.4057,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.87 to $25.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19593184,"source":{"system":"sec-edgar","filing":"0000899243-23-002444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323002444/doc4.xml","form_type":"4"}},{"id":2050962,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T21:00:13.000Z","date":"2023-01-18","kind":"sale","acquired":false,"shares":102467,"price":26.3149,"value":2696408.8583,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.12 to $26.8476. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19597221,"source":{"system":"sec-edgar","filing":"0000899243-23-002222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323002222/doc4.xml","form_type":"4"}},{"id":2050961,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-19T21:00:13.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":88372,"price":26.2385,"value":2318748.722,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.05 to $26.65. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19699688,"source":{"system":"sec-edgar","filing":"0000899243-23-002222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323002222/doc4.xml","form_type":"4"}}],"next_cursor":"2023-01-19T21:00:13.000000Z,2050961"}